The mechanisms that link anti-cancer therapy by TKI or anti-VEGF to glomerular cell dysfunction, hypertension, and nephrotic proteinuria are the subject of intense basic and translational research [6,7]. The gene discussed is VEGFA; the disease is hypertensive disorder.